Use of intravenous iron in cyanotic patients with congenital heart disease and/or pulmonary hypertension
Publié dansInternational Journal of Cardiology, vol. 267, p. 79-83
Date de publication2018
Résumé
Mots-clés
- Administration
- Intravenous
- Adult
- Aged
- Drug Monitoring/methods
- Erythropoiesis/drug effects
- Female
- Ferric Compounds/administration & dosage/adverse effects
- Heart Defects
- Congenital/blood/complications
- Hematinics/administration & dosage/adverse effects
- Hematologic Tests/methods
- Humans
- Hypertension
- Pulmonary/blood/complications
- Iron/administration & dosage/adverse effects/deficiency
- Male
- Maltose/administration & dosage/adverse effects/analogs & derivatives
- Middle Aged
- Polycythemia/diagnosis/etiology/therapy
- Retrospective Studies
- Treatment Outcome
- United Kingdom
- Congenital heart disease
- Cyanosis
- Eisenmenger syndrome
- Iron
- Pulmonary hypertension
Structure d'affiliation
Groupe de recherche
Citation (format ISO)
BLANCHE, Coralie et al. Use of intravenous iron in cyanotic patients with congenital heart disease and/or pulmonary hypertension. In: International Journal of Cardiology, 2018, vol. 267, p. 79–83. doi: 10.1016/j.ijcard.2018.05.062
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:128691
- DOI : 10.1016/j.ijcard.2018.05.062
- PMID : 29807779
ISSN du journal0167-5273